Cargando…

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside

Remdesivir, a monophosphate prodrug of nucleoside analog GS-441524, is widely used for the treatment of moderate to severe COVID-19. It has been suggested to use GS-441524 instead of remdesivir in the clinic and in new inhalation formulations. Thus, we compared the anti-SARS-CoV-2 activity of remdes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Sijia, Zandi, Keivan, Bassit, Leda, Ong, Yee Tsuey, Verma, Kiran, Liu, Peng, Downs-Bowen, Jessica A., McBrayer, Tamara, LeCher, Julia C., Kohler, James J., Tedbury, Philip R., Kim, Baek, Amblard, Franck, Sarafianos, Stefan G., Schinazi, Raymond F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	COVID-19 therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357487/ https://www.ncbi.nlm.nih.gov/pubmed/34870151 http://dx.doi.org/10.1016/j.crphar.2021.100045

Ejemplares similares

Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020)

Synthesis of 4′-Substituted-2′-Deoxy-2′-α-Fluoro Nucleoside Analogs as Potential Antiviral Agents
por: Kasthuri, Mahesh, et al.
Publicado: (2020)

Synthesis of Novel N(4)-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents
por: Amblard, Franck, et al.
Publicado: (2022)

Inpatient remdesivir versus nirmatrelvir-ritonavir in the progression of COVID-19
por: Patel, Dimple, et al.
Publicado: (2023)

Discovery of a 2′-Fluoro,2′-Bromouridine Phosphoramidate Prodrug Exhibiting Anti-Yellow Fever Virus Activity in Culture and in Mice
por: LeCher, Julia C., et al.
Publicado: (2022)

Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective
por: Gandhi, Zainab, et al.
Publicado: (2020)

Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis
por: Tao, Jun, et al.
Publicado: (2021)

Stewardship of Remdesivir Use in a Rural Community Hospital During the COVID-19 Pandemic
por: Tirupathi, Raghavendra, et al.
Publicado: (2021)

Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
por: Kelleni, Mina T.
Publicado: (2021)

Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
por: Zandi, Keivan, et al.
Publicado: (2021)

Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
por: Pradere, Ugo, et al.
Publicado: (2014)

Assessment of a Computational Approach to Predict Drug Resistance Mutations for HIV, HBV and SARS-CoV-2
por: Patel, Dharmeshkumar, et al.
Publicado: (2022)

Synthesis of 4′-Substituted Carbocyclic Uracil Derivatives and Their Monophosphate Prodrugs as Potential Antiviral Agents
por: Biteau, Nicolas G., et al.
Publicado: (2023)

Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19
por: Rabie, Amgad M.
Publicado: (2021)

Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021)

Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention
por: Rhazouani, Asmaa, et al.
Publicado: (2021)

Recent progress in the development of potential drugs against SARS-CoV-2
por: Chen, Jianmin, et al.
Publicado: (2021)

Host directed therapies: COVID-19 and beyond
por: Tripathi, Devavrat, et al.
Publicado: (2021)

The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response
por: Migo, William, et al.
Publicado: (2021)

Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?
por: Hooftman, Alexander, et al.
Publicado: (2021)

A research update: Significance of cytokine storm and diaphragm in COVID-19
por: Mittal, Ashwani, et al.
Publicado: (2021)

Hypoxia may be a determinative factor in COVID-19 progression
por: Grieb, Pawel, et al.
Publicado: (2021)

Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2
por: Bajad, Nilesh Gajanan, et al.
Publicado: (2021)

Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components
por: Verma, Devvret, et al.
Publicado: (2021)

Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19
por: Neta, Francisca Idalina, et al.
Publicado: (2021)

Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
por: Prasad, Kartikay, et al.
Publicado: (2021)

Approaches to hepatitis C treatment and cure using NS5A inhibitors
por: Kohler, James J, et al.
Publicado: (2014)

Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator
por: Hurwitz, Selwyn J., et al.
Publicado: (2021)

Drug Interactions in Lenacapavir-Based Long-Acting Antiviral Combinations
por: Cilento, Maria E., et al.
Publicado: (2022)

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
por: Whittington, Melanie D., et al.
Publicado: (2022)

Association of Surgical Delay and Overall Survival in Patients With T2 Renal Masses: Implications for Critical Clinical Decision-making During the COVID-19 Pandemic
por: Ginsburg, Kevin B., et al.
Publicado: (2021)

The Impact of Sociocultural Influences on the COVID-19 Measures—Reflections From Singapore
por: Eng Koon, Ong
Publicado: (2020)

Novel 1′-homo-N-2′-deoxy-α-nucleosides: synthesis, characterization and biological activity
por: Carnero, Alejandro, et al.
Publicado: (2020)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework
por: Sharma, Tanmay, et al.
Publicado: (2022)

Remdesivir: A giant step, or a tiptoe?
por: Dickinson, Gordon M.
Publicado: (2020)

Interaction between science advice and policymaking in time of COVID-19: a French perspective
por: Bruat, Camille, et al.
Publicado: (2022)

Procalcitonin as marker for bacterial coinfection among adult COVID-19 patients in a tertiary-care hospital in the Philippines
por: Pesebre, Angelie Lorraine, et al.
Publicado: (2022)

Successful Non-surgical Treatment of an Acute Calculous Cholecystitis in a Myeloma Patient with Covid-19: Case Report
por: Tang, Andy Sing Ong, et al.
Publicado: (2021)

A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
por: Rafia, Rachid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2lg6t71ftaopb0v728gul6bsfp